)
Mendus (IMMU) investor relations material
Mendus Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Positive long-term survival data from the ADVANCE II trial in MRD-positive AML presented at ASH, supporting broad post-remission positioning of vididencel in AML and CML, and expansion into ovarian cancer.
Updated clinical strategy aligns with evolving first-line AML treatments, including venetoclax and azacitidine combinations, and includes two new CML trials and a combination trial in AML with first patient enrollment expected in 2026.
Large-scale GMP manufacturing established with NorthX Biologics to support late-stage development and commercialization.
Corporate reorganization and staff reduction completed to offset increased clinical trial costs and balance costs ahead of anticipated 2026 trials.
ALISON trial in ovarian cancer confirmed safety and feasibility of vididencel as a combination therapy.
Financial highlights
Q4 net loss was SEK 41.1 million in 2025 (vs. SEK 38.7 million previously); full-year net loss was SEK 130.7 million in 2025.
Cash burn for Q4 was SEK 20.4 million; cash position at year-end was SEK 64.7 million.
SEK 52.5 million raised in a directed issue with insider support; SEK 50 million loan facility secured.
Cash runway extends into Q1 2027 with current financing and loan facility.
No revenue recognized; other operating income mainly from research collaborations and grants.
Capital allocation and financing
SEK 52.5 million raised via directed issue with insider support.
SEK 50 million loan facility secured with Fenja Capital; SEK 30 million tranche used in January.
Cash and cash equivalents at year-end: SEK 64.7 million.
Shareholders' equity at year-end: SEK 585.1 million.
Next Mendus earnings date
Next Mendus earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)